A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research

For genomic medicine research to be fully translated into clinical care, it is critical for researchers to engage stakeholders who ultimately regulate the use of genomic technologies and therapeutics within healthcare practice. Herein, we describe an example of how this might work.